Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

MAP Pharmaceuticals Phase 3 Trial Of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) announced that the efficacy portion of its first Phase 3 clinical trial evaluating its novel LEVADEX(TM) orally inhaled migraine therapy met all four primary endpoints. Additional endpoints showed that LEVADEX provided rapid and sustained pain relief for up to 48 hours after dosing.
generic viagra online
New Measures To Promote Quality In Darzi's One Year On Progress Report, UK
Plans to scrap some centrally driven targets and proposals for giving doctors and nurses control of their budgets were announced by Health Minister Lord Darzi today.
News of the day
Veterinary Practices In UK Need Good Access To Occupational Health
Staff working in UK veterinary practices lack access to good occupational health advice warns a new study published in the scientific journal, Occupational Medicine. The research, the first published benchmark of occupational health risk management by vet practices in the UK, showed that despite veterinary surgeons and nurses being exposed to many occupational hazards less than a third of practices had trained staff in health and safety and only 14% sought advice from occupational health professionals.
Public Health

New Tool Could Help Predict Dementia In Older People

Scientists have developed a new "risk index" that helps predict which individuals over the age of 65 may go on to develop dementia. The index is made up of a number of tests of different characteristics, which are put together to predict an older person"s risk of developing dementia. "This new risk index is a very useful tool that could help boost dementia research into treatments and prevention. However, it is very unlikely to be routinely available to older people in the UK because some of the tests are very expensive to carry out. One million people will develop dementia in the next ten years. Scientists investigating ways to prevent this devastating condition could use this tool to select people who are at a high risk. This would produce stronger results, reduce the number of participants needed in clinical trials and reduce the cost of research. Dementia research is drastically underfunded in the UK. We must start investing in research to improve care today and find a cure for tomorrow." Dr Susanne Sorensen Head of Research Alzheimer"s Society Full Reference D.E. Barnes, PhD,MPH, Predicting risk of dementia in older adults, May 13, 2009, online issue of Neurology®, the medical journal of the American Academy of Neurology. Alzheimer"s Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009